Oneness Biotech Co., Ltd. (4743.TWO)
TWD 63.0
(-10.0%)
TWD 63.0
(-10.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -414.87 Million TWD | 92.94% |
| 2022 | -5.39 Billion TWD | -10873.76% |
| 2021 | -49.13 Million TWD | -157.5% |
| 2020 | 85.44 Million TWD | -47.27% |
| 2019 | 162.05 Million TWD | 207.61% |
| 2018 | -150.58 Million TWD | 38.31% |
| 2017 | -244.1 Million TWD | -25.63% |
| 2016 | -194.3 Million TWD | 72.04% |
| 2015 | -694.88 Million TWD | -1987.43% |
| 2014 | -33.28 Million TWD | 51.73% |
| 2013 | -68.96 Million TWD | 68.6% |
| 2012 | -219.62 Million TWD | 33.4% |
| 2011 | -329.78 Million TWD | 57.58% |
| 2010 | -777.42 Million TWD | -14.6% |
| 2009 | -678.35 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -551.98 Million TWD | -45.02% |
| 2024 Q2 | -413.79 Million TWD | 25.03% |
| 2023 Q4 | -380.63 Million TWD | 55.58% |
| 2023 FY | -380.63 Million TWD | 92.94% |
| 2023 Q1 | -596.97 Million TWD | 88.93% |
| 2023 Q2 | -723.37 Million TWD | -21.17% |
| 2023 Q3 | -856.84 Million TWD | -18.45% |
| 2022 Q1 | 29.55 Million TWD | 160.15% |
| 2022 Q2 | 98.64 Million TWD | 233.79% |
| 2022 Q3 | -333.96 Million TWD | -438.54% |
| 2022 Q4 | -5.39 Billion TWD | -1514.45% |
| 2022 FY | -5.39 Billion TWD | -10873.76% |
| 2021 Q1 | -144.24 Million TWD | -268.81% |
| 2021 FY | -49.13 Million TWD | -157.5% |
| 2021 Q2 | -333.72 Million TWD | -131.36% |
| 2021 Q3 | 90.23 Million TWD | 127.04% |
| 2021 Q4 | -49.13 Million TWD | -154.45% |
| 2020 Q4 | 85.44 Million TWD | -15.56% |
| 2020 Q1 | 68.91 Million TWD | -57.47% |
| 2020 Q2 | 26.68 Million TWD | -61.27% |
| 2020 Q3 | 101.18 Million TWD | 279.17% |
| 2020 FY | 85.44 Million TWD | -47.27% |
| 2019 Q2 | 286.01 Million TWD | 20.33% |
| 2019 FY | 162.05 Million TWD | 207.61% |
| 2019 Q3 | 220.11 Million TWD | -23.04% |
| 2019 Q1 | 237.7 Million TWD | 257.85% |
| 2019 Q4 | 162.05 Million TWD | -26.38% |
| 2018 Q1 | -64.55 Million TWD | 73.56% |
| 2018 FY | -150.58 Million TWD | 38.31% |
| 2018 Q4 | -150.58 Million TWD | -327.52% |
| 2018 Q3 | -35.22 Million TWD | 16.6% |
| 2018 Q2 | -42.23 Million TWD | 34.57% |
| 2017 Q1 | -118.6 Million TWD | 38.96% |
| 2017 Q3 | -362.38 Million TWD | 1.76% |
| 2017 Q2 | -368.88 Million TWD | -211.01% |
| 2017 Q4 | -244.1 Million TWD | 32.64% |
| 2017 FY | -244.1 Million TWD | -25.63% |
| 2016 FY | -194.3 Million TWD | 72.04% |
| 2016 Q4 | -194.3 Million TWD | 66.56% |
| 2016 Q3 | -580.99 Million TWD | -0.36% |
| 2016 Q2 | -578.89 Million TWD | 8.1% |
| 2016 Q1 | -629.94 Million TWD | 9.35% |
| 2015 Q1 | -922.6 Million TWD | -2671.49% |
| 2015 FY | -694.88 Million TWD | -1987.43% |
| 2015 Q3 | -875.99 Million TWD | 10.29% |
| 2015 Q4 | -694.88 Million TWD | 20.67% |
| 2015 Q2 | -976.42 Million TWD | -5.83% |
| 2014 Q2 | -25.44 Million TWD | 43.28% |
| 2014 Q1 | -44.85 Million TWD | 34.96% |
| 2014 FY | -33.28 Million TWD | 51.73% |
| 2014 Q4 | -33.28 Million TWD | 44.08% |
| 2014 Q3 | -59.53 Million TWD | -134.01% |
| 2013 FY | -68.96 Million TWD | 68.6% |
| 2013 Q4 | -68.96 Million TWD | 70.02% |
| 2013 Q3 | -230 Million TWD | 34.66% |
| 2013 Q2 | -352.01 Million TWD | -90.79% |
| 2013 Q1 | -184.5 Million TWD | 15.99% |
| 2012 Q4 | -219.62 Million TWD | 22.85% |
| 2012 Q1 | -311.03 Million TWD | 5.69% |
| 2012 Q2 | -326.31 Million TWD | -4.92% |
| 2012 FY | -219.62 Million TWD | 33.4% |
| 2012 Q3 | -284.68 Million TWD | 12.76% |
| 2011 Q3 | -423.36 Million TWD | 37.4% |
| 2011 Q4 | -329.78 Million TWD | 22.11% |
| 2011 Q1 | -676.55 Million TWD | 12.98% |
| 2011 Q2 | -676.31 Million TWD | 0.03% |
| 2011 FY | -329.78 Million TWD | 57.58% |
| 2010 FY | -777.42 Million TWD | -14.6% |
| 2010 Q4 | -777.42 Million TWD | 0.0% |
| 2009 FY | -678.35 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -438.495% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -57.05% |
| Level Biotechnology Inc. | -453.9 Million TWD | 8.598% |
| Sagittarius Life Science Corp | -120.57 Million TWD | -244.097% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | -111.245% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 183.001% |
| GlycoNex Incorporation | -148.56 Million TWD | -179.253% |
| VBI | -25.31 Million TWD | -1538.798% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 1130.343% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 400.647% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -57.999% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 1456.786% |
| Visgeneer Inc. | 31.28 Million TWD | 1426.167% |
| Mycenax Biotech Inc. | 207 Million TWD | 300.415% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 39.043% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -209.029% |
| Neith Corporation | -150.31 Million TWD | -176.013% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 166.75% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -619.55% |
| Enimmune corporation | -314.15 Million TWD | -32.06% |
| TaiRx, Inc. | -147.86 Million TWD | -180.571% |
| CHO Pharma, Inc. | -203.79 Million TWD | -103.579% |
| EirGenix Inc. | -4.58 Billion TWD | 90.957% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -389.456% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 443.24% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 87.108% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | -30.704% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -1993.969% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 1404.279% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 917.413% |
| RBC Bioscience Corporation | 422.18 Million TWD | 198.269% |
| BiOptic Inc. | 12.59 Million TWD | 3394.774% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 56.07% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -308.803% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -151.173% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 231.76% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -545.012% |
| NaviFUS Corp. | -123.12 Million TWD | -236.946% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 660.26% |
| Sinew Pharma Inc. | -160.34 Million TWD | -158.741% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -71.513% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | -22.973% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | -0.543% |
| AP Biosciences Inc | -196.52 Million TWD | -111.104% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 160.238% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -3527.507% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 49.996% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 130.566% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -98.186% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | -188.384% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | -25.514% |
| TCI GENE Inc. | -689.25 Million TWD | 39.807% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -248.819% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 68.311% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 2125.475% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -307.262% |
| PharmaEngine, Inc. | -860.8 Million TWD | 51.804% |
| Savior Lifetec Corporation | -812.54 Million TWD | 48.941% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -38.307% |
| OBI Pharma, Inc. | -398.22 Million TWD | -4.182% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | -13.535% |
| Acepodia, Inc. | -6.02 Billion TWD | 93.109% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 87.804% |